The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a ...

For melanoma, the more serious type of skin cancer, survival rates have improved significantly to 92 per cent – meaning about ...

Almost 100% of people survive at least five years after being diagnosed with non-melanoma skin cancer, while for melanoma, ...

A new report shows good news for skin cancer patients with most people (close to 100 per cent) surviving at least five years ...

Predictive biomarkers of immunotherapy response are critical for clinical practice. In this study, baseline plasma sCD27 was ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes. Researchers have ...

Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...

Georgina V. Long, MD, MSc, discussed the long-term follow-up data for the combination of adjuvant dabrafenib and trametinib ...

Skin cancer survival rates are improving in Ireland. The hopeful news was revealed by the National Cancer Registry of Ireland ...

A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the ...